During a Q2 earnings call, the firm discussed progress on an FGFR2b antibody, a subcutaneous version of Blincyto, and ...

On August 4, Tom Lee, co-founder and managing partner of Fundstrat Capital, and chairman of BitMine, joined CNBC Television ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1100 ET – Bayer is expecting a historically high U.S. corn ...

The highest-paying dividend stocks in the Dow Jones Industrial Average right now are Verizon Communications (NYSE: VZ), ...

Impax Asset Management, an investment management company, released its “Impax US Sustainable Economy Fund” second-quarter ...

Women with an advanced form of womb cancer have been given fresh hope after a new treatment was given the green light for ...

German science and technology firm Merck is showcasing its latest materials innovations at K-Display 2025 in Seoul, ...

Thousands of women battling an advanced form of womb cancer have been offered renewed hope after a new treatment was approved for widespread use on the NHS. At such a critical moment in US history, we ...

The treatment combines pembrolizumab, made by Merck Sharp & Dohme, with chemotherapy drugs carboplatin and paclitaxel. Pembrolizumab is an immunotherapy that helps the immune system recognise and ...

Just 15% of women live for five years if they have been diagnosed with advanced (stage four) endometrial cancer – a cancer which usually starts in the lining of the womb. The treatment, pembrolizumab, ...